These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17983879)

  • 21. [Pharmacological prophylaxis and treatment of bronchopulmonary dysplasia].
    Groneck P; Speer CP
    Z Geburtshilfe Neonatol; 2005 Aug; 209(4):119-27. PubMed ID: 16138269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pitfalls, problems, and progress in bronchopulmonary dysplasia.
    Bhandari A; Bhandari V
    Pediatrics; 2009 Jun; 123(6):1562-73. PubMed ID: 19482769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia.
    Pantalitschka T; Poets CF
    Pediatr Pulmonol; 2006 Aug; 41(8):703-8. PubMed ID: 16779858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of infants with bronchopulmonary dysplasia in Germany.
    Thomas W; Speer CP
    Early Hum Dev; 2005 Feb; 81(2):155-63. PubMed ID: 15748970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Office management of bronchopulmonary dysplasia.
    Daigle KL; Cloutier MM
    Compr Ther; 1997 Oct; 23(10):656-62. PubMed ID: 9327181
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term pulmonary outcome in the preterm infant.
    Greenough A
    Neonatology; 2008; 93(4):324-7. PubMed ID: 18525217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic importance of the cytologic examination of tracheal lavage fluid in high-risk newborn infants].
    Zhekova N; Perenovska P; Kalaĭdzhieva M; Pramatarova T
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():9-13. PubMed ID: 18175391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
    Ballard PL; Truog WE; Merrill JD; Gow A; Posencheg M; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
    Pediatrics; 2008 Mar; 121(3):555-61. PubMed ID: 18310205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on pharmacologic approaches to bronchopulmonary dysplasia.
    Ghanta S; Leeman KT; Christou H
    Semin Perinatol; 2013 Apr; 37(2):115-23. PubMed ID: 23582966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure.
    Su PH; Chen JY
    J Perinatol; 2008 Feb; 28(2):112-6. PubMed ID: 17989696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging drugs for the prevention of bronchopulmonary dysplasia.
    Greenough A
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):537-46. PubMed ID: 18764728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lung disease after premature birth.
    Baraldi E; Filippone M
    N Engl J Med; 2007 Nov; 357(19):1946-55. PubMed ID: 17989387
    [No Abstract]   [Full Text] [Related]  

  • 33. PCO2 and room air saturation values in premature infants at risk for bronchopulmonary dysplasia.
    Kaempf JW; Campbell B; Brown A; Bowers K; Gallegos R; Goldsmith JP
    J Perinatol; 2008 Jan; 28(1):48-54. PubMed ID: 18033306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia.
    Mandell EW; Kratimenos P; Abman SH; Steinhorn RH
    Clin Perinatol; 2019 Jun; 46(2):291-310. PubMed ID: 31010561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of bronchopulmonary dyplasia (BPD).
    Am J Respir Crit Care Med; 2014 Apr; 189(8):P13-4. PubMed ID: 24735043
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bronchopulmonary dysplasia in ex-prematures approaching adulthood].
    Vrijlandt EJ; Gerritsen J; Duiverman EJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2445-51. PubMed ID: 18064864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To tube or not to tube babies with respiratory distress syndrome.
    Sekar KC; Corff KE
    J Perinatol; 2009 May; 29 Suppl 2():S68-72. PubMed ID: 19399013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventilatory strategies for the extremely premature infant.
    Greenough A; Premkumar M; Patel D
    Paediatr Anaesth; 2008 May; 18(5):371-7. PubMed ID: 18363629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.